May 5 (Reuters) – Swiss drugmaker Novartis said on Tuesday that it is set to cut around 220 jobs in Germany as part of the planned closure of a production site by the end of 2028.
The production site in Wehr, Germany, which manufactured tablets and capsules, is no longer competitive, the Swiss company said in a statement.
(Reporting by Marleen Kaesebier)
Comments